The chemosensitizer cyclosporin A enhances the toxic side-effects of doxorubicin in the rat
- 1 September 1994
- journal article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 120 (9) , 533-538
- https://doi.org/10.1007/bf01221030
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- In vitro and in vivo chemosensitizing effect of cyclosporin A on an intrinsic multidrug-resistant rat colon tumourZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Effects of Verapamil on the Acute Toxicity of Doxorubicin In VivoJNCI Journal of the National Cancer Institute, 1992
- Modulation of multidrug-resistant multiple myeloma by cyclosporinThe Lancet, 1992
- Expression of mdr1 and mdr3 Multidrug-resistance Genes in Human Acute and Chronic Leukemias and Association With Stimulation of Drug Accumulation by CyclosporineJNCI Journal of the National Cancer Institute, 1990
- Effects of Verapamil on Chronic Doxorubicin-Induced Cardiotoxicity in DogsJNCI Journal of the National Cancer Institute, 1990
- Addition of verapamil and tamoxifen to the initial chemotherapy of small cell lung cancer a phase I/II studyCancer, 1990
- Modulation by verapamil of vincristine pharmacokinetics and toxicity in mice bearing human tumor xenograftsBiochemical Pharmacology, 1989
- Expression of Multidrug Resistance Gene in Human CancersJNCI Journal of the National Cancer Institute, 1989
- Efficacy and cost of cardiac monitoring in patients receiving doxorubicinCancer, 1982
- Cardiotoxicity of adriamycin and related anthracyclinesCancer Treatment Reviews, 1976